RAPT Therapeutics, Inc. Accounts Payable
RAPT Therapeutics, Inc. had Accounts Payable of $2.10 million as of 2025-09-30, per its 10-Q filed 2025-11-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current
us-gaap:AccountsPayableCurrent · last filed 2025-11-06
- 2025-09-30: Accounts Payable, Current $2.10M.
- 2025-06-30: Accounts Payable, Current $4.19M.
- 2025-03-31: Accounts Payable, Current $1.29M.
- 2024-12-31: Accounts Payable, Current $1.27M.
| Period end | Accounts Payable, Current |
|---|---|
| 2025-09-30 | $2.10M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $4.19M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $1.29M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $1.27M 10-Q · filed 2025-11-06 |
| 2024-09-30 | $1.38M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $2.72M 10-Q · filed 2024-08-08 |
| 2024-03-31 | $6.77M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $5.18M 10-K · filed 2025-03-06 |
| 2023-09-30 | $5.30M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $2.69M 10-Q · filed 2023-08-11 |
| 2023-03-31 | $8.94M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $3.37M 10-K · filed 2024-03-07 |
| 2022-09-30 | $4.04M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $4.10M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $1.94M 10-Q · filed 2022-05-11 |
| 2021-12-31 | $2.00M 10-K · filed 2023-03-14 |
| 2021-09-30 | $4.02M 10-Q · filed 2021-11-10 |
| 2021-06-30 | $2.71M 10-Q · filed 2021-08-11 |
| 2021-03-31 | $3.13M 10-Q · filed 2021-05-11 |
| 2020-12-31 | $2.38M 10-K · filed 2022-03-10 |
| 2020-09-30 | $4.41M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $2.38M 10-Q · filed 2020-08-13 |
| 2020-03-31 | $3.41M 10-Q · filed 2020-05-14 |
| 2019-12-31 | $1.14M 10-K · filed 2021-03-11 |
| 2019-09-30 | $1.59M 10-Q · filed 2019-12-11 |
| 2018-12-31 | $1.77M 10-K · filed 2020-03-30 |